Pilot Therapeutics Holdings Inc PLTT:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 10/27/23 EDT
0.0001UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0001
  • 52 Week High0.00
  • 52 Week High Date10/27/23
  • 52 Week Low0.00
  • 52 Week Low Date05/11/23

Key Stats

  • Market Cap1,154.45
  • Shares Out11.54M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0001
  • 52 Week High0.00
  • 52 Week High Date10/27/23
  • 52 Week Low0.00
  • 52 Week Low Date05/11/23
  • Market Cap1,154.45
  • Shares Out11.54M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-5.285M
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-56.41%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pilot Therapeutics Holdings Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Pilot Therapeutics Holdings, Inc. is a holding company for Pilot Therapeutics, Inc. and is a specialty pharmaceutical company. Through lipid profiling and metabolism, the Company has developed a proprietary, lipid and genomic profiling research platform, termed Functional Liponomics. Using Functional Liponomics, the Company is developing novel, branded, therapeutic, pharmaceutical and over-the-counter (OTC) medical food products that are specifically designed to address...
Terrance Little
Chairman of the Board
Ross Consaul
Chief Executive Officer
Keith Wakeman
President
Steven Greenberg
Chief Financial Officer
Floyd Chilton Ph.D.
Chief Technology Officer, Director
Address
101 N. Chestnut Street, Suite 102
Winston Salem, NC
27101
United States